Figure 4. General down-regulation of serum RNase levels in cancer patients.
Serum RNase activities were determined for healthy individuals as well as 4 gastric cancer patients, 5 colon cancer patients, 5 lung cancer patients, 5 esophageal cancer patients, 5 kidney cancer patients, 5 uterus cancer patients and 5 pancreatic cancer patients. The RNase concentration of each serum sample was calculated by the standard curve and Kobs obtained from single-exponential equation. The relative serum RNase activity of each cancer patient was quantified by normalizing the cancer patient serum concentration with the average concentration of healthy individuals’ serum samples.